Αποτελέσματα Αναζήτησης
The Systolic Blood Pressure Intervention Trial (SPRINT) is a 2-arm, multicenter, randomized clinical trial designed to test whether a treatment program aimed at reducing systolic blood pressure (SBP) to a lower goal than currently recommended will reduce cardiovascular disease (CVD) risk. About 9250 participants with SBP ≥ 130 mm Hg and
The Systolic Blood Pressure Intervention Trial (SPRINT) was designed to test whether a treatment program aimed at reducing systolic blood pressure (SBP) to a lower goal (120mmHg) than currently recommended (140mmHg) could reduce cardiovascular disease (CVD) risk. The SPRINT study enrolled more than 9 000 people from USA.
29 Ιουν 2022 · The SPRINT (Systolic Blood Pressure Intervention Trial) demonstrated reductions in major cardiovascular disease events and mortality with an intensive systolic blood pressure (SBP) goal intervention.
The Systolic Blood Pressure Intervention Trial (SPRINT) found evidence of cardiovascular benefit with intensive lowering of systolic blood pressure (goal < 120 mm Hg)
23 Σεπ 2015 · The SPRINT trial showed that intensive BP control to SBP <120 mm Hg results in significant cardiovascular benefit in high-risk patients with hypertension compared with routine BP control to <140 mm Hg.
The NIH Systolic Blood Pressure Intervention Trial (SPRINT), an NHLBI-supported study, aims to answer three important research questions about how lowering systolic blood pressure to less than 120 millimeters of mercury (mm Hg) affects the cardiovascular system, kidneys, and brain.
Purpose—To describe the design considerations of the Systolic Blood Pressure Intervention Trial (SPRINT) and the baseline characteristics of trial participants. Methods—SPRINT is a multi-center, randomized, controlled trial that compares two strategies for treating systolic blood pressure: one targets the standard target of <140 mm Hg, and ...
